Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

IntroductionIn recent years, natural compounds have attracted wide attention for the treatment of liver cancer due to their therapeutic potential and reduced toxicity. Among these, Schisandrin B (Sch B), a primary bioactive component derived from Schisandra chinensis, has shown notable antitumor act...

Full description

Saved in:

Bibliographic Details
Main Authors:	Baoyi Jiang, Jie Yang, Qingtian Huang, Wei Li, Qian Peng, Huoye Gan, Tieli Peng, Leyi Yao, Ling Qi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Pharmacology
Subjects:	Schisandrin B hepatocellular carcinoma exosomes fibronectin 1 tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1547685/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Auranofin amplifies schisandrin A-induced apoptosis through ROS generation and inhibiting the PI3K/Akt pathway in hepatocellular carcinoma
by: Hyun Hwangbo, et al.
Published: (2025-06-01)

Membranous Overexpression of Fibronectin Predicts Microvascular Invasion and Poor Survival Outcomes in Patients with Hepatocellular Carcinoma
by: Yoon Jung Hwang, et al.
Published: (2025-03-01)

A comprehensive review of Schisandrin B’s preclinical antitumor activity and mechanistic insights from network pharmacology
by: Yanhua Fang, et al.
Published: (2025-02-01)

Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest
by: Yanhua Fang, et al.
Published: (2025-03-01)

The plasma levels of fibronectin in patients with ischemic heart failure
by: S. V. Fedorov
Published: (2014-12-01)

Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy
by: Ying Xu, et al.
Published: (2025-04-01)

Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway
by: Wang Cuiqiong, et al.
Published: (2020-01-01)

Multidimensional insights into exosomes in hepatocellular carcinoma: from genesis to clinical application
by: Xiang Zhang, et al.
Published: (2025-08-01)

Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice
by: Jiuchen Wan, et al.
Published: (2025-07-01)

Untensed fibronectin fibers: a novel hallmark of microthrombi
by: Arnaud Miéville, et al.
Published: (2025-08-01)

The role and potential mechanisms of exosomes in the progression of hepatocellular carcinoma
by: Tianhao Tong, et al.
Published: (2025-06-01)

Characterization of Fibronectin-Adherent, Non-Fibronectin-Adherent, and Explant-Derived Human Dental Pulp Stem Cell Populations
by: Heoijin Kim, et al.
Published: (2025-04-01)

Diagnostic value of exosomal N‐glycan profiles for microvascular invasion in hepatocellular carcinoma
by: Huijuan Feng, et al.
Published: (2024-12-01)

Inhibitory Effect of Exosomes Loaded with Ginsenoside Rh2 on Growth of Hepatocellular Carcinoma Cells
by: Meile LI, et al.
Published: (2025-07-01)

Clinical and prognostic significance of plasma fibronectin and circulating immune complexes in viral meningitis in children
by: O. G. Kimirilova, et al.
Published: (2023-06-01)

Glycosylated fibronectin as a biomarker to predict gestational diabetes mellitus in the first trimester of pregnancy
by: Indu Lata, et al.
Published: (2025-06-01)

The immune response against cancer is modulated by stromal cell fibronectin
by: Alexander Lubosch, et al.
Published: (2025-09-01)

Tumor-resident Malassezia can promote hepatocellular carcinoma development by downregulating bile acid synthesis and modulating tumor microenvironment
by: Weixi Shen, et al.
Published: (2025-04-01)

pH-sensitive fibronectin nanogels combined with UTMD for anti-atherosclerosis treatment through anti-inflammatory and antioxidant effects
by: Mengjiao Zhang, et al.
Published: (2025-08-01)

Exosomes in inflammation and cancer: from bench to bedside applications
by: Shiyuan Huang, et al.
Published: (2025-06-01)

Exosomes derived from syncytia induced by SARS-2-S promote the proliferation and metastasis of hepatocellular carcinoma cells
by: Huilong Li, et al.
Published: (2025-01-01)

Enhancement of the Bio-Responsiveness of PCL Nanofibers via the Combination of a Thiol Plasma-Polymerized Coating and Fibronectin Immobilization
by: Pegah Zahedifar, et al.
Published: (2025-06-01)

Nano-Biomimetic Fibronectin/Lysostaphin-Co-Loaded Silk Fibroin Dressing Accelerates Full-Thickness Wound Healing via ECM-Mimicking Microarchitecture and Dual-Function Modulation
by: Liu CT, et al.
Published: (2025-06-01)

Predictive value of Glycosylated Fibronectin (GlyFn)/Placenta Growth Factor (PlGF) ratio for high-risk pregnancies: a cohort study
by: Wahyudi Wirawan, et al.
Published: (2025-07-01)

Tissue-engineered fibrillar fibronectin matrices are not only lovely, but also functional for regenerative medicines and in vitro model systems
by: Seungkuk Ahn
Published: (2024-12-01)

A Prospective Cohort Study on Serum Glycosylated Fibronectin as a Biomarker for Early Prediction of Preeclampsia
by: Vibhuti Thakur, et al.
Published: (2025-06-01)

Lenvatinib‐resistant hepatocellular carcinoma promotes malignant potential of tumor‐associated macrophages via exosomal miR‐301a‐3p
by: Yuhei Waki, et al.
Published: (2024-11-01)

Progress in research into exosomes in breast cancer microenvironment
by: Kang-Di LI, et al.
Published: (2021-06-01)

Predictive effect and clinical diagnosis significance of exosome-related genes for nonalcoholic fatty liver disease-related hepatocellular carcinoma
by: Xiaoqian Ding, et al.
Published: (2025-07-01)

Tumor-derived exosomes and their application in cancer treatment
by: Afsaneh Javdani-Mallak, et al.
Published: (2025-07-01)

Changes in various forms of fibronectin in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass – a prospective, observational study
by: Anna Lemańska-Perek, et al.
Published: (2024-12-01)

Serum Fibronectin Levels Increased Significantly Following the Administration of an Inactivated SARS-CoV-2 Vaccine: A Prospective Observational Study
by: Zhao B, et al.
Published: (2025-04-01)

Histodynamics of Natural Killer Cells from a Healthy Donor Exposed to Exosomes from the Blood of Hepatocellular Carcinoma Patients
by: Indria Asrinda, et al.
Published: (2024-12-01)

Exosomal miR-6126 as a novel therapeutic target for overcoming resistance of anti-cancer effect in hepatocellular carcinoma
by: Hyemin Hwang, et al.
Published: (2024-12-01)

Nanorough Surface of Fibronectin Grafted Bioactive Zirconia Dental Implants by Using Glow Discharge Plasma Promotes Osseointegration in a Rabbit Model
by: Aung LM, et al.
Published: (2024-11-01)

Exosomes in cartilage microenvironment regulation and cartilage repair
by: Han Longfei, et al.
Published: (2025-03-01)

Fetal fibronectin and microorganisms in vaginal fluid of women with complicated pregnancies
by: Anette Rossel Goffeng, et al.
Published: (1997-06-01)

Association of left ventricular structural remodeling types with fibronectin deficiency in patients with multivessel coronary artery disease
by: A. R. Mingalimova, et al.
Published: (2023-12-01)

Diagnostic significance of endotoxin and antitoxic opsonin – fibronectin in the blood flow in purulent-necrotic inflammatory of the lower limb in patients with diabetes mellitus
by: A. V. Pikuza, et al.
Published: (2023-11-01)

The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts
by: Ilenia Masi, et al.
Published: (2025-02-01)